South Georgia Capital’s GSK GSK Stock Holding History

South Georgia Capital’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$62K	Sell	1,280 -640	-33%	-$33.3K	0.15%	43
2015 Q2	$100K	Sell	1,920 -1,040	-35%	-$58.6K	0.2%	47
2015 Q1	$171K	Sell	2,960 -1,200	-29%	-$68.8K	0.32%	33
2014 Q4	$222K	Buy	4,160 +1,440	+53%	+$80.6K	0.4%	35
2014 Q3	$156K	Buy	+2,720	New	+$167K	0.23%	48

Other funds holding GSK

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

South Georgia Capital's GSK Position: Q3 2015 in Review

South Georgia Capital reduced its GSK (GSK) stake by 33% in Q3 2015, selling an estimated $33.3K and leaving 1,280 shares worth $62K. The position accounts for 0.15% of the portfolio, ranked #43.

South Georgia Capital first reported a position in GSK in Q3 2014 and has held it in 5 quarters since. The position peaked at $222K in Q4 2014. 706 funds tracked by Wall St. Rank hold GSK as of Q3 2015.

South Georgia Capital held 1,280 shares of GSK worth $62K as of Q3 2015.
South Georgia Capital sold 640 GSK shares in Q3 2015, an estimated $33.3K.
GSK made up 0.15% of South Georgia Capital's portfolio in Q3 2015, its #43 holding.
South Georgia Capital first reported a position in GSK in Q3 2014 and has held it in 5 quarters since.
South Georgia Capital's GSK position peaked at $222K in Q4 2014.
706 funds tracked by Wall St. Rank held GSK as of Q3 2015.

Based on South Georgia Capital's 13F filing for Q3 2015, filed 10 Nov 2015.